DEG leads round for Indonesian mRNA vaccine developer
German development finance organisation DEG has contributed USD 8m as the lead investor in a new funding round for Etana Biotechnologies Indonesia, supported by Yunfeng Capital, HighLight Capital, and East Ventures.
The overall size of the round was not disclosed. It follows a Series B, also of undisclosed size, led by Yunfeng in September 2022. HighLight took part in that round as well. Legend Capital took the lead...
More on Southeast Asia
Latest News
VC investors primed for exit with China Youzan reorganisation
Hillhouse Capital and Matrix Partners China are set for liquidity events after China Youzan, an e-commerce software-as-a-service (SaaS) business listed in Hong Kong, agreed to take full control of its key subsidiary for HKD 2.6bn (USD 334.5m).
Goldman backs Japan taxi-hailing player Go
Goldman Sachs Asset Management (GSAM) has committed JPY 10bn (USD 75m) in Series D funding to Go Inc, operator of a Japan-based taxi-hailing app.
AVCJ daily bulletin returns May 29
AVCJ’s daily bulletin will not be published on May 26 due to a public holiday in Hong Kong.
Digital bank Tyme wins funding for SE Asia, Africa expansion
Tyme Group, an emerging markets-focused digital banking group with operations in the Philippines and South Africa, has raised USD 77.8m in pre-Series C funding. A portion of the proceeds will be used for expansion into other markets in Southeast Asia.